Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2003
03/26/2003CN1405303A Broad-spectrum, high-temperatur-resistant, high-specific-activity phytase, and its coding gene and expression
03/26/2003CN1405302A New-mutant carbamyl-phosphate synthesized enzyme and method for producing compound derivated from carbamyl-phosphate
03/26/2003CN1405299A Genetically engineered bacterial strain spiramycin streptomycete WSJ-195 of bite spiramycin
03/26/2003CN1405298A Yeast recombinant strain and IFN alpha-2b interferon purifying method
03/26/2003CN1405297A North winterworm summerherb high-yield cultivation and its new-product processing technique
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1404735A Compound microbiological bacterial agent and its production method
03/26/2003CN1103820C Method for detection of methylthioadenosine phosphorylase deticiency in mammallian cells
03/26/2003CN1103819C Alpha-ketoglutaric dehydrogenase gene
03/26/2003CN1103813C Method for producing detoxication enzyme by using detoxification engineering bacterium to make high-density fermentation
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103537C Aseptic culture method of bisporous mushroom with corn stalks
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003US6538182 Genetic modification of plants to control age-related or environmental stress-induced senescence; use in extending shelf-life and slowing spoilage of plant cuttings, flowers, seeds, fruits, vegatables, or leaves
03/25/2003US6538177 Compositions and methods for fumonisin detoxification
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538122 Process for producing microbial transglutaminase
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6537966 Follistatin-3
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537815 Method of altering the expression of csrB to modify the properties of a cell
03/25/2003US6537795 Supercapsulated mutated strain of streptococcus from culture medium free of metal ions
03/25/2003US6537794 Chemokine
03/25/2003US6537792 Mutation pair with a disulfide bond inbetween; reduces isomaltose formation; use in production of corn sweeteners, organic products for beverages and fuel
03/25/2003US6537791 Mammalian DNA-dependent ATPase a polypeptides and fusions thereof
03/25/2003US6537790 Esterase genes and uses of the same
03/25/2003US6537786 Genes encoding exopolysaccharide production
03/25/2003US6537785 Methods of treating lysosomal storage diseases
03/25/2003US6537779 T7 promoter-based expression system
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537767 Method for screening antimycotically active substances
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537756 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
03/25/2003US6537583 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating
03/25/2003US6537570 Method of biological control
03/25/2003US6537558 Methods of producing and using virulence attenuated poxR mutant bacteria
03/25/2003US6537552 Vaccine adjuvant
03/25/2003US6537547 Antitumor agents; side effect reduction even at high dosage
03/25/2003US6537544 Oatmeal gruel fermiented with strains of lactobacillus plantarum JI:1 and species AC:3; prophylaxis or treatment of disturbances in equine intestinal microflora and gastritis
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2382249A1 Microorganisms for use in the measurement of environmental factors
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2159342C Apparatus for separating by dielectrophoresis
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2083401C Identification of a novel human receptor tyrosine kinase gene
03/21/2003CA2404706A1 Novel mutants of the formate dehydrogenase from candida boidinii
03/20/2003WO2003023050A2 Method for recovering and analyzing a cellular component of cultured cells without having to harvest the cells first
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023044A2 Process for the production of l-amino acids using coryneform bacteria
03/20/2003WO2003023036A1 Sulfated fucogalactan digesting enzyme gene
03/20/2003WO2003023032A2 High throughput directed evolution by rational mutagenesis
03/20/2003WO2003023030A2 Aminopeptidase
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023017A1 Method for transforming amycolatopsis sp. dsm 9991 and dsm 9992
03/20/2003WO2003023016A2 Method for producing fine chemicals
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023013A2 Novel nucleic acids and polypeptides
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022989A2 Therapeutic agents that inhibit the tup1 pathway
03/20/2003WO2003022884A2 Methods for construction and screening of libraries of chemokine variants
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022868A2 Metal binding proteins and associated methods
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022205A2 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002090545A9 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
03/20/2003WO2002090494A3 Isolation, characterization, cloning and use of a mushroom lectin
03/20/2003WO2002088353A3 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof
03/20/2003WO2002088340A3 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002074966A3 Process for the preparation of l-amino acids by using coryneform bacteria
03/20/2003WO2002072846A9 Synthetic genes and bacterial plasmids devoid of cpg
03/20/2003WO2002072142A3 Modulation of a balance between the gut mucosal immune system and the intestinal microflora
03/20/2003WO2002060934A3 IDENTIFICATION OF THE ANTI-σ28 FACTOR IN HELICOBACTER PYLORI, IN CAMPYLOBACTER JEJUNI AND IN PSEUDOMONAS AERUGINOSA AND APPLICATION THEREOF
03/20/2003WO2002060317A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046417A3 Adipocyte complement related protein zacrp3x2
03/20/2003WO2002042447A3 Surface transfection and expression procedure
03/20/2003WO2002026961A3 Production process of surfactin
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002022673A3 Proteins participating in nucleotide metabolism and genes coding for the same from ashbya gossypii
03/20/2003WO2002022667A9 Twin-arginine translocation in bacillus
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002014551A3 Bioluminescent methods for direct visual detection of environmental compounds
03/20/2003WO2002004619A3 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2002002591A3 Peptides for use in culture media